[7]
Nirogi, R.V.S.; Deshpande, A.D.; Chindhe, A.K.; Kambhampati, R.; Shinde, A.K.; Dubey, A.K. Synthesis and biological screening of 3-chloro-2-piperazinylmethyl-N-aryl sulfonamide indole derivatives as 5-HT6 receptor ligands: Part III. Pharma Chem., 2012, 4, 909-914.
[9]
Masand, N.; Gupta, S.P.; Khosa, R.L. Synthesis of substituted sulphonamide derivatives and evaluation of their effect on spatial memory in Alzheimer’s models. World J. Pharm. Res., 2017, 6(15), 1140-1154.
[36]
Zenova, A.; Gong, W.; Chowdhury, S.; Wilson, M.; Burford, K.; Andrez, J.; Shuart, N.G.; Tari, P.K.; Kwan, R.; Khakh, K. Effect of bridged pyrrolidine rings on SAR and physicochemical properties in a series of Nav1.6 selective aryl sulfonamide inhibitors. Abstracts of Papers 258th ACS National Meeting, San Diego, USA2019.
[61]
Liang, C. Aryl-sulfonamide and aryl-sulfone derivatives as TRPML modulators. Patent WO 2018208630 A1, 2018.
[62]
Sinha, N.; Karche, N.; Hatnapure, G.D.; Hajare, A.K.; Palle, V.; Kamboj, R.K.; Kumar, R. Preparation of biaryl derivatives as nAChR modulators. Patent WO 2013005153 A1, 2013.
[63]
Takashi, O.; Yoichi, O.; Taro, S. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors. Patent US8772269 (B2), 2014.
[64]
Smith-Jones, M.; Zhang, H.; Carlin, S.D. Preparation of aryl and heteroaryl sulfonamide compounds useful as carbonic anhydrase modulators and as imaging agents for diagnosis or prognosis of carbonic anhydrase IX-positive tumors. Patent WO 2010147666 A1, 2010.
[65]
Krall, N.; Decurtins, W.; Neri, D.; Scheuermann, J.; Wichert, M. Small molecule drug conjugates. Patent WO 2015114171 A1, 2015.
[66]
Spyvee, M. Preparation of substitutes aryl sulfonamides as dUTPase inhibitors for the treatment of cancer. Patent WO 2018098209 A1, 2018.
[67]
Abe, Y.M. Preparation of pyrrolopyridazines as inhibitors of phosphodiesterase IV (PDE IV) and production of tumor necrosis factor-α (TNF-α). Patent WO 2004063197 A1, 2004.
[68]
Bearss, D.J.; Grand, C.L.; Liu, X-H.; Vankayalapati, H. Piperazinylpyrimidoindole derivatives as protein kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer. Patent WO 2008055233 A1, 2008.
[69]
Corbett, T.H.; Grossman, C.S.; Lobb, K.L.; Shih, C.; Hipskind, A.; Lin, H-S. Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents. Patent WO 2002098848 A1, 2002.
[70]
Ungashe, S.; Wright, J.J.; Pennell, A.; Wei, Z.; Melikan, A. Preparation of aryl sulfonamides as antagonists of CCR9 receptor. Patent US 7420055 B2, 2008.
[71]
Cappel, M. Azaaryl-1H-pyrazol-1-yl benzenesulfonamides as CCR9 antagonists and their preparation. Patent US 20180009797 A1, 2018.
[72]
Ben-Tal, N.; Armen, R.S.; Eisenlohr, L.C.; Belani, J.; Miller, M.; Fish, I.; Kalid, O. Antiviral agents for drug-resistant influenza. Patent WO 2017106820 A1 20170622, 2017.
[73]
Sauzeau, V.; Loirand, G.; Lebreton, J.; Tessier, A.; Quemenier, A. Preparation of benzene-sulfonamides as Rac1 inhibitors and uses thereof for inducing bronchodilation. Patent WO 2018224560 A1, 2018.
[74]
Zhang, Z. Preparation of aryl sulfonamide compounds as carbonic anhydrase inhibitors for treatment of cancer metastases. Patent WO 2017004543 A1, 2017.
[75]
Potter, P.M.; Hyatt, J.L.; Morton, C.L.; Beroza, P.P.; Damoradan, K.V. Amide, aryl sulfonamide, aryl urea, and α,β-diketone carboxylesterase inhibitors and uses thereof. Patent WO 2005021721 A2, 2005.
[76]
Noronha, G.; Cao, J.; Gritzen, C.; Mak, C.C.; Mcpherson, A.; Pathak, V.; Renick, J.; Soll, R.M.; Zeng, B.; Dneprovskaia, E. Preparation of 2-amino-5-substituted pyrimidine kinase inhibitors and use in therapy. Patent WO 2008008234 A1, 2008.
[77]
Nirogi, R.; Kambhampati, R.S.; Shinde, A.K.; Daulatabad, A.V.; Dwarampudi, A.R.; Kandikere, N.V.; Vishwakarma, S.; Jasti, V. Aminoalkoxy arylsulfonamide compounds and their use as 5-HT6 ligands Patent IN 285812 B, 2017.
[78]
Marron, B.E.; Fritch, C.; Markworth, C.J.; Maynard, A.T.; Swain, N.A. N-Azolyl aminocarbonyl arylsulfonamide derivatives as inhibitors of ion channels and their preparation, pharmaceutical compositions and use in the treatment of diseases. Patent WO 2008118758 A1, 2008.
[79]
Beaudoin, S.; Johnson, M.S.; Marron, B.E.; Suto, M.J. Sodium channel inhibitors. Patent WO 2009012241 A1, 2009.
[80]
Wang, X.; Fulp, A.; Marron, B.; Beaudoin, S.; Seconi, D.; Suto, M. Aryl sulfonamide compound sodium channel inhibitors, and their therapeutic use. Patent WO 2007056099 A2, 2007.
[81]
Rossello, A.; Nuti, E.; Tuccinardi, T.; Orlandini, E. Arylsulfonamide derivatives, especially dimeric hydroxamic acid-containing amino acids, metalloproteases inhibitors and their preparation, pharmaceutical compositions and use in the treatment of degenerative disorders. WO 2010010080 A1, 2010.
[82]
Rossello, A.; Nuti, E.; Orlandini, E.; Balsamo, A.; Tuccinardi, T. Arylsulfonamide derivatives as metalloproteases inhibitors and their preparation, pharmaceutical compositions and use in the treatment of degenerative disorders. Patent WO 2008113756 A2, 2008.
[83]
Degraffenreid, M.R.; He, X.; Powers, J.; Sun, D.; Yan, X. Preparation of aryl sulfonamides as inhibitors of hydroxysteroid dehydrogenases (HSDs). Patent WO 2005063247 A1, 2005.
[84]
Supuran, C.T.; Scozzafava, A.; Pastorekova, S.; Pastorek, J. Use of sulfonamide carbonic anhydrase IX-specific inhibitors for the diagnosis, prognosis, and treatment of preneoplastic and neoplastic diseases. Patent US 20060057068 A1, 2006.
[85]
Testi, R.; Incani, O. Compositions and methods for treating Friedreich’s ataxia. Patent WO 2011070444 A2, 2011.
[86]
Lawrence, H.; Ge, Y.; Sebti, S.M.; Guida, W. Proteasome inhibitors for selectively inducing apoptosis in cancer cells. Patent US 8673910B2, 2014.
[87]
Smith, N.D.; Bonnefous, C.; Payne, J.E.; Hoffman, T.Z.; Wash, L.; Hassig, C.A.; Scranton, S.A. Multicyclic sulfonamide compounds as inhibitors of hystone deaetylase for the treatment of disease. Patent WO 2007067994 A1, 2007.
[88]
Malecha, J.W.; Noble, S.A.; Wiley, B.M.; Hoffman, T.Z.; Bonnefous, C.; Sertic, M.; Wash, L.; Smith, N.D.; Hassig, C.A.; Scranton, S.A.; Payne, J.E.; Hager, J. Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease. Patent US 20070027184 A1, 2007.
[89]
Van Loevezijn, A.; Iwema Bakker, W.I.; Stoit, A.; Rensink, A.A.M.; Venhorst, J.; Van der Neut, M.A.W.; De Haan, M.; Kruse, C.G. Pyrazoline carboxamidine derivatives as 5-HT6 antagonists. Patent WO 2009115515 A1, 2009.
[90]
Vernier, J-M.; Rowlings, C.E.; Girardet, J-L.; Dimock, S.; Quart, B.; Miner, J.N. Combinations of MEK inhibitors and RAF kinase inhibitors and uses thereof. Patent US 8648116 B2, 2014.
[91]
Bindi, S.; Carenzi, D.; Motto, I.; Pulici, M. N-Aryl sulfonamide derivatives as kinase inhibitors and their preparation. Patent WO 2017220477, 2017.
[92]
Budzik, B.W.; Cooper, A.W.J.; Corbett, D.F.; Jin, J.; Laine, D.I.; Wang, Y.; Moore, M.L.; Rivero, R.A.; Shi, D.; Wang, F. Preparation of biaryl amines as M3 muscarinic acetylcholine receptor antagonists. Patent WO 2005087236 A1, 2005.
[93]
Beausoleil, A-M.; Ryan, H. Preparation of aryl sulfonamides useful as bcl family antagonists for the treatment of senescent related diseases and cancer. Patent WO 2019241567 A1, 2019.
[94]
Dai, M.; Guan, B.; Bennett, R.A.; Burdi, D.F.; Ghosh, S.; Li, G.; Minor, C.J.; Tracy, J. Preparation of aryl sulfonamides as inhibitors of the chemokine receptor CCR8 for the treatment of Th2-and eosinophil-mediated diseases. Patent US 20050085518 A1, 2005.
[95]
Allison, B.D.; Rabinowitz, M.H.; Rosen, M.D.; Woods, C.R. Preparation of aryl sulfonamide compounds as modulators of the CCK2 receptor for treating cancer, gastrointestinal disorders, and other diseases. Patent WO 2008124524 A2, 2008.
[96]
Supuran, C.T.; Benedini, F.; Biondi, S.; Ongini, E. Preparation of nitrate esters of (hetero)arylsulfonamide carbonic anhydrase inhibitors as agents for treating eye disorders and cancer. Patent WO 2008071421 A1, 2008.
[97]
Ungashe, S.; Wei, Z.; Basak, A.; Charvat, T.T.; Chen, W.; Jin, J.; Moore, J.; Zeng, Y.; Punna, S.; Dairaghi, D. Prepa-ration of aryl and heteroaryl sulfonamides as CCR2 antagonists. WO 2006076644 A2, 2006.
[98]
Ungashe, S.; Wright, J.J.; Pennell, A.; Wei, Z.; Melikian, A. Preparation of aryl sulfonamides as antagonists of CCR9 receptor. Patent WO 2005112925 A1, 2005.
[99]
Ungashe, S.; Wright, J.J.; Pennell, A. Preparation of aryl sulfonamides as antagonists of CCR9. Patent WO 2005113513 A2, 2005.
[100]
Zhao, C.; Malecha, J.W.; Noble, S.A.; Duron, S.G.; Lindstrom, A.K.; Shiau, A.K. Preparation of aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders. Patent US 20050234046 A1, 2005.
[101]
Dennis, A.; Hollander, M.C.; Nicklaus, M.; Peach, M.; Chemler, S.R. Method of treating or preventing cancer. Patent WO 2011009059 A2, 2011.
[102]
Gaillard, P.; Quattropani, A.; Pomel, V.; Rueckle, T.; Klicic, J.; Church, D. Preparation of pyrazine derivatives, particularly N-[3-(oxyphenylamino)quinoxalin-2-yl] sulfonamides, as PI3K Inhibitors. Patent WO 2007023186 A1, 2007.
[103]
Wright, J.J. Treatment of asthma with aryl sulfonamides that modulate chemokine receptors. Patent US 20080214672 A1, 2008.
[104]
Rigby, A.C.; Balk, S.; Shanmugasundaram, K.; Shen, H.C.N.N. N-(1,3-Benzodioxol-5-ylmethyl) benzenesulfonamides as androgen receptor inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer Patent WO 2012082862 A2, 2012.
[105]
Irwin, J.; Sutphin, P.; Chan, D.; Turcotte, S.; Giaccia, A.; Lai, E.; Razorenova, O.; Hay, M.; Bonnet, M.; Sun, C. Glucose transporter-1 (GLUT1) inhibitors for treatment of cancer. Patent WO 2012100223 A1, 2012.
[106]
Popovici-Muller, J.; Salituro, F.G.; Saunders, J.O.; Travins, J.; Yan, S. Preparation of aryl sulfonamide diarylurea derivatives as inhibitors of mutant isocitrate dehydrogenase ½ for treating cancer. Patent WO 2014062511 A1, 2014.
[107]
Armer, R.; Guisot, N.E.S.; Lucas, C. Preparation of pyrazolo[3,4-d]pyrimidines as Bruton's tyrosine kinase inhibitors. Patent WO 2015140566 A1, 2015.
[108]
Vernier, J-M.; Rowlings, C.E.; Girardet, J-L.; Dimock, S.; Quart, B.; Miner, J.N. Preparation of N-[2-(arylamino)aryl] sulfonamide compounds as MEK kinase inhibitors. Patent WO 2009018233 A1, 2009.
[109]
Gregan, F.; Remko, M.; Sluciakova, E.; Knapikova, J. Sulfonamide derivatives as carboanhydrase inhibitors and the process for their preparation, pharmaceutical compositions and use in the treatment of glaucoma. Patent WO 2008130332 A1, 2008.
[110]
Nakamura, T.; Sakagami, K.; Konishi, K.; Yamamoto, K.; Masuda, S.; Matsuda, Y.; Okada, K.; Shibata, T.; Ohta, H.; Yasuhara, A. Preparation of heteroaryl-pyrazole derivatives as group II mGlu receptor antagonists. Patent WO 2012020820 A1, 2012.
[111]
Neidhart, W.; Nettekoven, M.H.; Pflieger, P. Preparation of thiazoles as NPY5 receptor antagonists. Patent US 20050038089 A1, 2005.
[112]
Singh, J.; Gurney, M.; Hategan, G. Arylsulfonamide acid peri-substituted bicyclics and their preparation, pharmaceutical compositions, and prostanoid EP3 receptor binding activity for treatment of occlusive artery disease. Patent WO 2006044405 A1, 2006.
[113]
Schmidt, B.; Flockerzi, D.; Hatzelmann, A.; Zitt, C.; Barsig, J.; Marx, D.; Kley, H-P.; Kautz, U. Preparation of thio-containing phenylphenanthridines as PDE4 inhibitors for the treatment of respiratory diseases. Patent WO 2005087744 A1, 2005.
[114]
Muto, T.; Tanaka, T.; Maruoka, H.; Imajo, S.; Tomimori, Y.; Sato, K.; Yagi, T. Preparation of 1,4-diazepane-3,5- dione derivatives as chymase inhibitors and pharmaceutical use thereof. Patent WO 2007139230 A1, 2007.
[115]
Fukami, H.; Ito, A.; Imajo, S. Preparation of quinazoline derivatives as chymase inhibitors. Patent WO 2000010982 A1, 2000.
[116]
Dachary, E.; Dargazanli, G.; Estenne, B.G.; Marabout, B.; Rakotoarisoa, N.; Roger, P.; Sevrin, M. reparation of N-[phenyl(piperidin-2-yl)methyl]benzamides as specific inhibitors of glycine transporters glyt1 and/or glyt2. Patent FR 2842805 A1, 2004.
[117]
Sutphin, P.; Chan, D.; Turcotte, S.; Denny, W.A.; Hay, M.; Giddens, A.C.; Bonnet, M.; Giaccia, A. Preparation of heteroaryl benzamides useful in treating diseases. Patent WO 2011011514 A1, 2011.
[118]
Shim, H.; Shi, Q.; Renren, B. Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition. Patent WO 2017160832 A1, 2017.
[119]
McComas, C.C.; Cohn, S.T.; Crawley, M.L.; Fensome, A.; Goldberg, J.A.; Jenkins, D.J.; Kim, C.Y.; Mahaney, E.; Mann, C.W.; Marella, M.A. Aryl sulfamide derivatives as monoamine reuptake inhibitors and their preparation and methods of their use. Patent WO 2008073459 A1, 2008.
[120]
Nilsson, C. Use of an aryl sulfonamide compound inhibitor of 11b-hydroxysteroid dehydrogenase type 1 for promoting wound healing. Patent WO 2004113310 A1, 2004.
[121]
Lai, Y.; Wang, F.; Zou, Y.; Xu, Q.; Guo, W.; Wang, Y.; Sun, Q.; Li, Y. Benzenesulfonamide indoleamine 2,3- dioxygenase 1 (IDO1) inhibitor, its preparation method and application. Patent CN 106928101 A, 2017.
[122]
Rao, Z.; Yang, C.; Lou, Z.; Xiao, Y.; Wang, J.; Wang, T.; Liu, W.; Xia, Q. Application of sulfonamide compound in inhibiting NDM-1 activity. Patent CN 103191091 A, 2013.
[123]
Liu, X.; Chen, H.N.N. N-(2-(N-Acylaminomethyl)phenyl) thiazole-4-carboxamide derivatives as direct factor Xa inhibitors and their preparation, pharmaceutical compositions and use in the treatment of platelet disorders Patent CN 104016944 A, 2014.
[124]
Wang, X.; Hu, Y.; Ye, Q.; Hu, X. N-benzyl-N-aryl sulfonamide derivative, its preparation method and application for treating autoimmune disease mediated by Kv1.3. Patent CN 109651297 A, 2019.
[125]
Zhao, Z.; Liu, J.; Lu, Y.; Chen, Y.; Bi, L.; Xu, S.; Wang, J.; Gu, Y. N-4-(isopimaric acid acylamino) phenyl. Aryl sulfonamide compound useful in treatment of cancer and its preparation. Patent CN 106431998 A, 2017.
[126]
Huang, Z. Arylsulfonamide-piperazine derivatives as DPP-IV inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diabetes. Patent CN 101486688 A, 2009.
[127]
Kayakiri, H.; Abe, Y.; Hamashima, H.; Sawada, H.; Ishibashi, N.; Setoi, H.; Oku, T.; Yamasaki, N.; Imoto, T.; Hiramura, T. Preparation of sulfonamides as medicines. Patent WO 2000034277 A1, 2000.
[128]
Ueda, I.; Taniguchi, K.; Saito, Y.; Katsura, Y. Benzenesulfonamide derivatives Jpn. Patent JP 58124758 A, 1983.
[129]
Kim, G.Y.; Ahn, J.H.; Kang, S.G.; Lee, S.D.; Bae, M.A.; Ahn, S.H.; Kim, H.Y.; Jung, W.H.; Kang, N.S. Preparation of arylsulfonamide derivatives containing cyclopropyl moiety as 11β-HSD1 inhibitors. Patent KR 2012111347 A, 2012.
[136]
De Benedetti, G.; Frassineti, C. A theoretical study of the structure-activity relationship in diaryl sulphones, comparison with sulpha drugs. J. Mol. Struct. Theochem., 1983, 91, 191-196.
[215]
Srivastava, P.; Srivastava, S.P.; Soni, A.K.; Singh, R.K. Comparative study of interaction of benzene sulfonamides with Zn-metal, Zn2+-ion and carbonic anhydrase (Zn2+-CA). J. Chem. Pharm. Res., 2012, 4, 3107-3115.
Download PDF Flyer